UniSuper Management
Overview
UniSuper Management is the wholly owned administration and management company for UniSuper, one of Australia's largest industry superannuation funds, which invests in a diverse portfolio of assets including shares, property, infrastructure, and private equity.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PlasmaLeap Technologies | Mar 2026 | Series A | Co-investor |
| Ferronova | Dec 2025 | Series A | Co-investor |
| Morse Micro | Sep 2025 | Series C | Co-investor |
| Celosia Therapeutics | Nov 2024 | Series A | Co-investor |
| Kinoxis Therapeutics | Aug 2024 | Series B | Co-investor |
Key People
Benedict Davies
Principal Policy Adviser, Office of the CEO
James Atherton
Lead People Partner
Jim Bacskos
Risk Partner - Technology Delivery & Information
Maria Minas
Communications & Engagement Partner
Daniel Stutt
Portfolio Manager
James Ewinger
Senior Portfolio Manager
Mark Himpoo
Senior Portfolio Manager
Sam Heffernan
Portfolio Manager - Fixed Interest (Credit)
Thomas Tam
Senior Portfolio Manager Asset Allocation Committee Member, Head of Global Equities
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
